Description

8-Indolizinol, Octahydro-1,6,7-Tris(Phenylmethoxy)-, 1S-(1.Alpha.,6.Beta.,7.Alpha.,8.Beta.,8A.Beta.)- is a complex, stereochemically defined indolizine derivative that serves as a critical advanced intermediate in sophisticated organic synthesis. Its value lies in its functionalized structure, which provides a versatile chiral scaffold for constructing complex molecules with high pharmacological relevance. This compound is primarily needed by research institutions and pharmaceutical development teams focused on creating novel active pharmaceutical ingredients (APIs), particularly in areas like alkaloid chemistry and drug discovery.

Application

• Pharmaceutical Intermediate: A key chiral building block for the synthesis of complex alkaloids and other bioactive molecules in drug discovery and development pipelines.
• Organic Synthesis Research: Used in academic and industrial R&D for methodological studies in stereoselective synthesis and heterocyclic chemistry.
• Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Chemical Biology Probe Development: Utilized as a core structure for developing molecular probes to study biological pathways and enzyme interactions.
• Agrochemical Synthesis: Potential intermediate in the research and development of novel, high-value crop protection agents.
• Catalyst Ligand Precursor: Can be further functionalized to create novel chiral ligands for asymmetric catalysis.

Basic Information

Product Name	8-Indolizinol, Octahydro-1,6,7-Tris(Phenylmethoxy)-, 1S-(1.Alpha.,6.Beta.,7.Alpha.,8.Beta.,8A.Beta.)-
CAS No.	156150-89-9
Molecular Formula	C30H35NO3
Molecular Weight	457.60 g/mol
Synonyms	(1S,6R,7R,8R,8aR)-Octahydro-1,6,7-tris(benzyloxy)indolizin-8-ol; 1,6,7-Tris-O-benzyl-8-indolizinol; (1S,6R,7R,8R,8aR)-1,6,7-Tris(benzyloxy)octahydroindolizin-8-ol; 8-Indolizinol, octahydro-1,6,7-tris(phenylmethoxy)-, (1S,6R,7R,8R,8aR)-; 1,6,7-Tris-O-benzyl-swainsonine derivative; 8-Hydroxy-1,6,7-tris(benzyloxy)octahydroindolizine (stereoisomer)
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. We provide material that meets high-purity requirements for research and development use. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are available upon request. Production can be aligned with cGMP guidelines for advanced pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Keep the container sealed in a dry, inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 97.0%
Specific Rotation	Contact for details
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.